Table 2 GO terms of differential expressed genes
From: Human brain arteriovenous malformation: an analysis of differential expressed genes
GO | P-value (%) | Q-value (%) | Protein | FC |
|---|---|---|---|---|
Protein binding | 6.34E-16 | 0.0 | HCLS1 | 2.53 |
LYN | 1.70 | |||
ARHGDIB | 1.80 | |||
ARHGAP18 | 1.97 | |||
CD3D | 2.57 | |||
Copper ion binding | 3.74E-05 | 0.0 | SLC31A2 | 2.21 |
SPARC | 2.71 | |||
Receptor activity | 7.35E-05 | 0.0 | MS4A6A | 3.83 |
FCGR2A; | 1.82 | |||
ADRA2C | 0.44 | |||
KLRK1 | 0.39 | |||
Sodium ion binding | 1.11E-04 | 0.0 | SLC13A3 | 0.38 |
SLC13A4 | 0.21 | |||
Calcium ion binding | 2.40E-04 | 0.0 | SPARC | 2.71 |
CAPN3 | 3.37 | |||
VCAN | 2.60 | |||
Sugar binding | 2.59E-04 | 0.0 | VCAN | 2.60 |
KLRK1 | 0.39 | |||
Mitogen-activated protein kinase | 3.90E-04 | 0.0 | DUSP2 | 0.36 |
GTPase activator activity | 4.23E-04 | 0.0 | ARHGDIB | 1.80 |
ARHGAP18 | 1.97 | |||
Actin binding | 7.86E-04 | 0.0 | GMFG | 2.29 |
TMSB4Y | 1.51 | |||
Hydrolase activity | 3.34E-01 | 0.0 | RNASE6 | 2.81 |
DUSP2 | 0.36 |